Inhibrx to host webcast clinical update on ozekibart in late-line colorectal cancer
Share
Listen to the news
Inhibrx to host webcast clinical update on ozekibart in late-line colorectal cancer
  • Inhibrx schedules live webcast presentation for April 21, 2026 at 1:30 p.m. PT.
  • Presentation set to provide clinical update from Phase 1/2 study of ozekibart (INBRX-109) plus FOLFIRI in late-line colorectal cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibrx Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA38961) on April 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending